Standout Papers

Rivaroxaban Versus Vitamin K Antagonist in Antiphospholipid Syndrome 2019 2026 2021 2023 196
  1. Rivaroxaban Versus Vitamin K Antagonist in Antiphospholipid Syndrome (2019)
    Josep Ordi‐Ros, Luís Sáez-Comet et al. Annals of Internal Medicine

Citation Impact

55 standout
Sub-graph 1 of 23

Citing Papers

Diagnosis and Management of Cerebral Venous Thrombosis: A Scientific Statement From the American Heart Association
2024 Standout
Ironing out the details of ferroptosis
2024 Standout

Works of Antoni Castro being referenced

Rivaroxaban Versus Vitamin K Antagonist in Antiphospholipid Syndrome
2019 Standout
Blood Letting in High-Ferritin Type 2 Diabetes
2002

Author Peers

Author Epidemiology Rheumatology CCM Hematology Last Decade Papers Cites
Antoni Castro 474 412 341 351 104 2.1k
A. Budziak 3 59 603
Svetlana Pavlukhina 2 2 2 5 519
Cinzia Pagano 24 11 3 60 1.4k
J. C. Greeff 1 1 1 48 732
Chenxi Li 19 1 6 1 11 265

All Works

Loading papers...

Rankless by CCL
2026